BRIDGE LOAN AGREEMENT dated as of March 15, 2020 between PROGENICS PHARMACEUTICALS, INC., as Borrower and LANTHEUS MEDICAL IMAGING, INC., as LenderBridge Loan Agreement • March 16th, 2020 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMarch 16th, 2020 Company Industry JurisdictionTHIS BRIDGE LOAN AGREEMENT (as amended, restated or otherwise modified from time to time, this “Agreement”) is made and entered into as of March 15, 2020 by and between PROGENICS PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”) and LANTHEUS MEDICAL IMAGING, INC., a Delaware corporation (the “Lender”).